CIP
THC icon

Convergence Investment Partners’s Tenet Healthcare THC Stock Holding History

Convergence Investment Partners’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,763
Closed -$506K – 284
2025
Q1 		$506K Sell
3,763
-7,842
-68% -$1.03M 0.14% 196
2024
Q4 		$1.46M Buy
11,605
+2,351
+25% +$350K 0.33% 111
2024
Q3 		$1.54M Buy
9,254
+1,158
+14% +$175K 0.41% 75
2024
Q2 		$1.08M Buy
+8,096
New +$975K 0.31% 101
2022
Q1 		– Sell
-3,003
Closed -$245K – 252
2021
Q4 		$245K Sell
3,003
-928
-24% -$67.8K 0.12% 164
2021
Q3 		$261K Sell
3,931
-1,523
-28% -$108K 0.14% 156
2021
Q2 		$365K Sell
5,454
-36
-0.7% -$2.23K 0.16% 136
2021
Q1 		$285K Sell
5,490
-204
-4% -$10.3K 0.13% 166
2020
Q4 		$227K Buy
+5,694
New +$184K 0.11% 164
2020
Q1 		– Sell
-34,698
Closed -$1.32M – 264
2019
Q4 		$1.32M Buy
+34,698
New +$1.04M 0.38% 92
2018
Q4 		– Sell
-81,507
Closed -$2.32M – 364
2018
Q3 		$2.32M Sell
81,507
-63,720
-44% -$2.1M 0.47% 68
2018
Q2 		$4.88M Buy
145,227
+145,143
+172,789% +$4.51M 0.68% 34
2018
Q1 		$2K Buy
+84
New +$1.67K ﹤0.01% 957
2017
Q2 		– Sell
-38,449
Closed -$681K – 404
2017
Q1 		$681K Buy
+38,449
New +$713K 0.1% 279

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Convergence Investment Partners's THC Position: Q2 2025 in Review

Convergence Investment Partners sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 3,763 shares — an estimated $506K sold.

Convergence Investment Partners first reported a position in THC in Q1 2017 and held it in 14 quarters. The position peaked at $4.88M in Q2 2018. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

  • Convergence Investment Partners reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
  • Convergence Investment Partners sold 3,763 Tenet Healthcare shares in Q2 2025, an estimated $506K.
  • Convergence Investment Partners first reported a position in Tenet Healthcare in Q1 2017 and held it in 14 quarters.
  • Convergence Investment Partners's Tenet Healthcare position peaked at $4.88M in Q2 2018.
  • 626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Convergence Investment Partners's 13F filing for Q2 2025, filed 1 Aug 2025.